By Mike Schultz, Spectrum Plastics Group, Vice President of Innovation and Development
Minimally invasive surgeries (MIS) that utilize steerable catheter systems represent an expanding market in the healthcare space. As the variety of catheter-based procedures continues to grow, with physicians and therapies demanding tools and technologies that increase access and performance, the steerable catheter market is wide open for innovation.
MIS procedures, especially cardiovascular and neurovascular applications, must often navigate tortuous pathways to gain access to more distal vessels and specific targeted anatomy. The success of these procedures depends on advanced catheter systems that deliver therapies to precise locations through narrow access points, such as the femoral artery. As MIS procedures become more delicate and complex, physicians require enhanced control and steerability of catheters to precisely locate and deploy the treatment without dama…